Introduction {#s1}
============

Over two-thirds of U.S. adults are overweight or obese and therefore at increased risk of developing type 2 diabetes ([@B1],[@B2]). Physicians are in an excellent position to identify these individuals and advise them to lose weight, which has been shown to reduce the risk of developing diabetes and to improve a variety of health outcomes ([@B3],[@B4]). However, few physicians provide their patients with counseling to achieve weight loss ([@B5]). The physician counseling literature suggests that having physicians advise their patients to lose weight, while referring them to an effective program or allied health counselors rather than trying to offer counseling themselves, may be the most effective model for obesity treatment ([@B3]).

Unfortunately, there are few options for reimbursed weight-loss programs to which physicians can refer their patients ([@B6]). Behavioral weight-loss programs (BWLs) such as the lifestyle intervention used in the Diabetes Prevention Program (DPP) produce weight losses of 7--10%, reduce the risk of developing type 2 diabetes, and improve cardiovascular disease risk factors ([@B7]--[@B10]). However, these programs typically involve frequent group or individual sessions, are costly to both patients and providers, may not appeal to large numbers of patients seeking to lose weight, and are not widely available outside of research studies ([@B8]). Efforts to translate the DPP for delivery by medical and allied health professionals (e.g., in primary care practices) and in community settings such as the YMCA have produced a modest mean weight loss of 3.2--4.3% of initial body weight as determined by meta-analysis ([@B11]). There are also continued concerns about the cost, reach, accessibility, and long-term sustainability of these programs, which have relied heavily on in-person treatment delivery that is not well financed by the current health care system ([@B11]).

Shortcomings associated with in-person treatment delivery may be mitigated by adapting BWLs for Internet delivery ([@B12],[@B13]), but there have been few randomized controlled trials testing these programs as a resource for physicians to refer their overweight and obese patients. In early studies of patients recruited through health care providers, the Internet was used to provide tailored or personal advice but not a structured BWL with a clearly defined curriculum of training in empirically validated behavioral weight-loss strategies. Attrition was high in these studies, and weight losses were quite limited ([@B14],[@B15]). More recent studies of physician referral to Internet programs have used stronger behavioral programs but have provided substantial contact with health care coaches in person, by phone, and/or via e-mail ([@B16]--[@B19]). Although weight losses have been better in some of these studies \[e.g., 4.8 kg at 12 months ([@B16]) and 5.1 kg at 24 months ([@B18])\], the human interaction once again makes these programs more expensive to deliver and less easily disseminated.

The primary objective of the Rx Weight Loss Trial was to examine the weight losses produced by a nearly fully automated Internet BWL compared with a healthy eating and activity Internet newsletter control condition, after a 3-month program and at 3-month follow-up, among patients who were randomized after accepting a referral to the trial by their physicians.

Research Design and Methods {#s2}
===========================

Design Overview {#s3}
---------------

Participants were referred to the Rx Weight Loss Trial by 35 physicians at 5 primary care and 1 endocrinology practice in Rhode Island. Physicians identified potential participants during routine care and reviewed the study and inclusion/exclusion criteria with them. Physicians were especially encouraged to refer individuals with one or more obesity-related comorbidities, such as diabetes, hypertension, or metabolic syndrome. A referral form was signed by both the physician and patient and faxed to the researchers. Interested participants were contacted by the research staff, phone screened for eligibility, and scheduled for an orientation session, at which time further information was provided about the study and informed consent completed. Participants were scheduled for a baseline assessment and randomization/program kickoff visit ∼1 week later.

Participants were randomly assigned to a 3-month Internet behavior therapy program or Internet-Delivered Eating and Activity (IDEA) control condition with information on healthy eating habits and physical activity. During both the randomization/program kickoff visit and in their lesson materials, participants in both conditions received information pertaining to a healthy rate of weight loss and safe engagement in physical activity. The importance of regular contact with the referring physician for adjustments in medications was stressed. Access to the Internet interventions ended after 12 weeks in both groups. Both groups were assessed at the end of the 3-month program (posttreatment) and after 3 additional months of follow-up and received \$25 and \$50, respectively, for completing the assessments. Study procedures were approved by the Institutional Review Board of The Miriam Hospital.

Participants {#s4}
------------

Participants were 154 overweight or obese English-speaking individuals with a BMI of 25--45 kg/m^2^, age 18--70 years old, with access to a personal computer and the Internet. Exclusion criteria included a weight loss of ≥5% of initial body weight within the last 6 months, current participation in another weight-loss program or current use of weight-loss medication, participation in a weight-loss program at the study clinic within the last 2 years, living with another study participant, pregnant or breastfeeding within the last 6 months, a plan to become pregnant or move to a new geographic region within 6 months, current chemotherapy or radiation treatment for cancer, untreated serious mental illness, or hospitalization for mental illness within the last 12 months.

Randomization and Interventions {#s5}
-------------------------------

Participants were randomly assigned to one of the two treatment conditions using a computer-generated permuted blocking procedure, stratified by sex. A 1:1 randomization scheme was used. The allocation sequence was concealed until a patient consented to participate and had completed the baseline assessment.

### Internet Behavioral Intervention {#s6}

The Internet Behavioral Intervention (IBI) program included 12 weekly multimedia behavioral lessons, a website for submitting self-monitoring data, and weekly automated feedback provided to the participant on their progress to date. Participants were introduced to the IBI program at the 60-min randomization/program kickoff visit; they were given a goal of losing 1 to 2 lbs/week and achieving a total weight loss of ≥10% of initial body weight. To accomplish this, they were prescribed a calorie goal of 1,200--1,500 kcal/day depending on initial body weight with ≤30% calories from fat (40--60 g of fat/day) and a physical activity goal that gradually increased to 200 min/week of physical activity using activities similar in intensity to brisk walking. The remainder of the randomization/program kickoff visit was used to teach skills for self-monitoring daily food intake, physical activity minutes, and body weight. Participants received paper diaries and a calorie reference book for this purpose.

Standard behavioral strategies for changing their eating and activity were taught to the participants by having them view weekly 10--15-min interactive multimedia behavioral weight-loss lessons. In contrast to previous studies using static lessons with text and graphics ([@B20]), interactive lessons incorporating video, animation, audio, quizzes, and exercises for goal setting, planning, and problem-solving were developed to improve patient engagement ([@B21]). These lessons were based on strategies used in the DPP and Look AHEAD trials and included topics such as restaurant eating, changing the home environment, and social support ([@B9],[@B22]). Daily values for body weight, caloric intake, fat intake (g), and physical activity minutes were submitted at least weekly to the Rx Weight Loss website. In response to their submissions, participants received a weekly automated tailored feedback message. The feedback messages were generated via an algorithm that compared participants' self-reported values to their goals for weekly and overall weight loss, caloric intake, and physical activity minutes. Participants received praise for meeting goals and, when goals were not met, received specific recommendations for behavioral strategies to implement, along with support and encouragement. Automated e-mail reminder messages were sent weekly to participants who were not using the study website. Although in our prior research we found that human feedback was associated with larger weight losses than automated messages ([@B20]), we used automated messages in this trial because of the cost savings and ease of dissemination.

At weeks 4, 8, and 12, a letter was sent to the referring physician (and copied to the participant) indicating the number of weeks the participant had submitted data and their weight loss at that point. The letters were intended to provide physicians with information on the outcome of their referral, facilitate communication about health behaviors between physicians and patients, and enhance patients' sense of accountability for their health and health behaviors.

### IDEA {#s7}

Participants in this education-only control condition were seen at the randomization/program kickoff visit and instructed to access the Rx Weight Loss website at least once weekly to view a new printable lesson with static text and graphics in the Adobe portable document format. These newsletters provided general educational information on the benefits of losing weight and healthy eating and physical activity habits. Participants were not taught behavioral weight-loss strategies and were not instructed to self-monitor their behaviors, but were encouraged to explore online resources such as choosemyplate.gov, which contains information and tools for weight loss. This condition mimicked what patients may receive during routine care: a recommendation to lose weight accompanied by general educational information. IDEA also served as a method for controlling for access to Internet-based resources.

Outcomes and Follow-up {#s8}
----------------------

The primary outcome was change in body weight (kg, percent of initial body weight). Weight was measured in the research setting at baseline, 3 months (end of treatment), and 6 months (follow-up) in light street clothing, without shoes, and on a calibrated scale by blinded research staff. A secondary outcome was engagement with the Internet-based treatment system, which was measured by the number of weeks (out of 12) that participants logged in to the website, and, in the IBI group only, the number of weeks that calories, physical activity minutes, and body weight were reported for at least 5 of the 7 days. At baseline, participants reported their demographic characteristics and physician-diagnosed medical conditions. At baseline, 3, and 6 months, participants reported the number of weeks in the past 3 months that they had: *1*) reduced the number of calories consumed; *2*) decreased fat intake; *3*) increased fruits and vegetables consumed; and *4*) increased exercise levels. These items were drawn from the Weight Control Practices questionnaire used in the Look AHEAD trial ([@B23]).

Statistical Analysis {#s9}
--------------------

PASW Statistics 19 (SPSS, Inc., 2009, Chicago, IL; <http://www.spss.com>) was used for all analyses. Changes in weight and levels of engagement with the Internet-based treatment system were examined via separate repeated-measures ANOVA that followed the intent-to-treat (ITT) principle in which missing data were replaced by baseline weights (assuming no weight loss). A secondary ITT analysis using multiple imputation by chained equations was used to confirm the pattern of results from the initial ITT analysis given that replacing missing data with baseline values could adversely affect tests of statistical significance ([@B24]). Given no difference in the pattern of results, the more conservative analysis with missing data replaced by baseline weights (assuming no weight loss) was selected for detailed reporting. Correlations were used to evaluate associations between engagement with the Internet-based treatment system and change in weight. Paired and independent samples *t* tests, respectively, were used to evaluate within-groups changes in rates of weight-control behaviors and to compare IBI and IDEA on rates of weight-control behaviors at baseline, 3, and 6 months. Unless noted otherwise, tests of significance were conducted at α = 0.05; all tests were two-tailed. This trial was designed to have 80% power to detect significant between-groups differences in weight loss of ≥2 kg at 3 and 6 months after randomization with 250 participants. An interim analysis comparing between-groups weight loss was conducted with 150 participants (4 more were in progress at the time), which resulted in early stopping of the trial due to clear evidence of efficacy. The analysis, and decision to stop the trial, were consistent with the α spending function approach to interim data analysis in which a more stringent criterion for statistical significance is used, in this case *P* \< 0.004 ([@B25]).

Results {#s10}
=======

Recruitment and Retention {#s11}
-------------------------

The CONSORT diagram is depicted in [Fig. 1](#F1){ref-type="fig"}. A total of 154 participants were randomized; 84.4% completed the assessment at the end of the 3 months, and 79.2% completed the 6 month follow-up. All attrition was attributed to loss of contact with participants. Retention rates were comparable in IBI and IDEA at both 3 months (83.1% in IBI vs. 85.7% in IDEA) and 6 months (79.2% in IBI vs. 79.2% in IDEA). There were also no statistically significant differences in baseline characteristics between participants who did and did not attend a postbaseline assessment.

![Flow of participants through the trial. The CONSORT flow diagram includes data on physician referrals, patient enrollment, allocation to treatment groups, follow-up, and primary analysis.](9fig1){#F1}

Sample Characteristics {#s12}
----------------------

Participants' baseline characteristics are reported in [Table 1](#T1){ref-type="table"}. Eighty percent of the participants were women. Participants averaged 53.2 (10.9) years of age and had an entry weight of 94.9 (16.4) kg. The most commonly endorsed physician-diagnosed medical conditions were hypertension (*n* = 80; 51.9% of sample), arthritis (*n* = 53; 34.4% of sample), cancer history (*n* = 22; 14.3% of sample), and type 2 diabetes (*n* = 20; 13.0% of sample). At baseline, IDEA participants reported higher rates of decreasing fat intake as a weight-loss strategy; there were no other statistically significant baseline differences between IBI and IDEA.

###### 

Baseline characteristics of participants assigned to the IBI and IDEA control conditions

                                  Full sample (*N* = 154)   IBI condition (*n* = 77)   IDEA condition (*n* = 77)
  ------------------------------- ------------------------- -------------------------- ---------------------------
  Sex, no. (%)                                                                         
   Men                            31 (20.1)                 15 (19.5)                  16 (20.8)
   Women                          123 (79.9)                62 (80.5)                  61 (79.2)
  Age, mean (SD), years           53.2 (10.9)               52.8 (10.2)                53.6 (11.6)
  Race, no. (%)                                                                        
   American Indian                4 (2.6)                   1 (1.3)                    3 (3.9)
   Asian                          2 (1.3)                   1 (1.3)                    1 (1.3)
   Black                          7 (4.6)                   3 (3.9)                    4 (5.2)
   White                          136 (88.3)                70 (90.9)                  66 (85.7)
   Other                          10 (6.5)                  5 (6.5)                    5 (6.5)
  Ethnicity, no. (%)                                                                   
   Hispanic                       8 (5.2)                   5 (6.5)                    3 (3.9)
   Non-Hispanic                   146 (94.8)                72 (93.5)                  74 (96.1)
  Marital status, no. (%)                                                              
   Single                         33 (21.4)                 14 (18.2)                  19 (24.7)
   Married                        97 (63.0)                 50 (64.9)                  47 (61.0)
   Separated/divorced             24 (15.6)                 13 (16.9)                  11 (14.3)
  Education, no. (%)                                                                   
   High school or less            19 (12.3)                 5 (6.5)                    14 (18.2)
   Some college                   44 (28.6)                 27 (35.1)                  17 (22.1)
   College or university degree   32 (20.8)                 14 (18.2)                  18 (23.4)
   Graduate degree                59 (38.3)                 31 (40.2)                  28 (36.3)
  Weight, mean (SD), kg           94.9 (16.4)               95.5 (16.8)                94.3 (16.1)
  BMI, mean (SD), kg/m^2^         34.9 (4.8)                34.9 (4.7)                 34.9 (5.0)

There were no statistically significant differences between IBI and IDEA at baseline.

ITT Analysis {#s13}
------------

Group-specific changes in weight at months 3 and 6 are depicted in [Table 2](#T2){ref-type="table"} and [Fig. 2](#F2){ref-type="fig"}. The IBI condition produced significantly greater weight loss than IDEA at 3 months, 5.5 (4.4) vs. 1.3 (2.4) kg, and at 6 months, 5.4 (5.6) vs. 1.3 (4.1) kg (*P* \< 0.0001 for the overall effect of group). Moreover, 53% of IBI lost at least 5% of their body weight at 3 months, and 48% met the 5% weight goal at 6 months. Of the individuals in IBI that lost at least 5% of their body weight at 3 months, 34% lost at least an additional 1 kg from 3 to 6 months (mean \[SD\] loss of 2.9 \[1.7\] kg), 29% gained at least 1 kg from 3 to 6 months (mean \[SD\] gain of 2.8 \[1.2\] kg), and 37% were within 1 kg of their 3-month weight at 6 months. Twenty-one percent of IBI participants lost at least 10% of their body weight at each assessment point. The proportion of IBI participants achieving clinically significant weight losses exceeded those in IDEA ([Table 2](#T2){ref-type="table"}). Nearly a third (25--30%) of participants in IDEA gained weight at 3 and 6 months, respectively, whereas this occurred in only 2--7% of participants assigned to IBI ([Supplementary Fig. 1](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc14-1474/-/DC1)). The secondary analysis using multiple imputation produced the same pattern of results and statistically significant effects (not shown).

###### 

Change in weight at months 3 and 6 (ITT) for participants assigned to the IBI and IDEA control condition

                                                      IBI (*n* = 77)   IDEA (*n* = 77)
  --------------------------------------------------- ---------------- -----------------------------------------------
  Weight loss (kg), mean (SD)                                          
   3 months                                           5.5 (4.4)        1.3 (2.4)[\*\*\*](#t2n1){ref-type="table-fn"}
   6 months                                           5.4 (5.6)        1.3 (4.1)[\*\*\*](#t2n1){ref-type="table-fn"}
  Weight loss (% of initial weight), mean (SD)                         
   3 months                                           5.8 (4.4)        1.4 (2.7)[\*\*\*](#t2n1){ref-type="table-fn"}
   6 months                                           5.6 (5.6)        1.4 (4.6)[\*\*\*](#t2n1){ref-type="table-fn"}
  Participants with no loss or weight gain, no. (%)                    
   3 months                                           1 (1.3)          20 (26.0)[\*\*\*](#t2n1){ref-type="table-fn"}
   6 months                                           5 (6.5)          23 (29.9)[\*\*\*](#t2n1){ref-type="table-fn"}
  Participants with ≥5% weight loss, no. (%)                           
   3 months                                           41 (53.3)        7 (9.1)[\*\*\*](#t2n1){ref-type="table-fn"}
   6 months                                           37 (48.1)        12 (15.6)[\*\*\*](#t2n1){ref-type="table-fn"}
  Participants with ≥10% weight loss, no. (%)                          
   3 months                                           16 (20.8)        1 (1.3)[\*\*\*](#t2n1){ref-type="table-fn"}
   6 months                                           16 (20.8)        4 (5.2)[\*\*](#t2n1){ref-type="table-fn"}

\*\**P* \< 0.01, \*\*\**P* \< 0.001 for comparison of IBI and IDEA.

![Change in weight at months 3 and 6 in the ITT population for participants assigned to the IBI and IDEA control condition. Means with 95% CI bars.](9fig2){#F2}

Engagement With the Website {#s14}
---------------------------

IBI and IDEA did not differ significantly in the number of weeks (out of 12) that the website was used during the initial 3-month program (10.0 ± 3.0 in IBI and 9.5 ± 3.1 in IDEA; *P* = 0.301). Using the website for a greater number of weeks was associated with larger weight loss in the IBI condition (*r* = 0.41; *P* \< 0.001) but not in the IDEA condition (*r* = 0.18; *P* = 0.110).

Participants in the IBI condition reported their daily caloric intake, physical activity minutes, and daily weight on the intervention website at least 5 days out of the week on 6.7 (4.7) of the 12 weeks. Frequency of reporting was correlated with weight loss (*r* = 0.54; *P* \< 0.001).

Weight-Control Behaviors {#s15}
------------------------

The frequency of each weight-loss behavior increased significantly from baseline to 3 months in IBI and IDEA (*P* values \<0.001), but IBI participants reported making changes during a greater number of weeks during this 3-month period ([Table 3](#T3){ref-type="table"}). Although the frequency of these changes decreased over time ([Table 3](#T3){ref-type="table"}), at 6 months, IBI participants still reported a greater frequency of reducing calorie and fat intake than IDEA.

###### 

IBI and IDEA control condition participants' reports of their weight-control behaviors

                                   Baseline    3 months    6 months                                                                                                                                                                                                                                                            
  -------------------------------- ----------- ----------- ---------- -------------------------------------------- ------------------------------------------- --------- -------------------------------------------------------------------------- -------------------------------------------------------------------------- -------
  Reduce calories consumed         2.1 (3.7)   2.0 (3.1)   0.942      11.0 (2.5)[\*](#t3n1){ref-type="table-fn"}   5.9 (4.7)[\*](#t3n1){ref-type="table-fn"}   \<0.001   6.6 (5.2)[\*](#t3n1){ref-type="table-fn"}[‡](#t3n2){ref-type="table-fn"}   4.3 (4.8)[\*](#t3n1){ref-type="table-fn"}[‡](#t3n2){ref-type="table-fn"}   0.013
  Decrease fat intake              0.9 (2.4)   2.2 (3.6)   0.009      10.6 (2.9)[\*](#t3n1){ref-type="table-fn"}   5.9 (5.0)[\*](#t3n1){ref-type="table-fn"}   \<0.001   7.2 (4.9)[\*](#t3n1){ref-type="table-fn"}[‡](#t3n2){ref-type="table-fn"}   5.1 (5.2)[\*](#t3n1){ref-type="table-fn"}                                  0.023
  Increase fruits and vegetables   2.9 (4.0)   3.4 (4.4)   0.481      9.9 (3.9)[\*](#t3n1){ref-type="table-fn"}    7.6 (4.6)[\*](#t3n1){ref-type="table-fn"}   0.002     7.8 (5.0)[\*](#t3n1){ref-type="table-fn"}[‡](#t3n2){ref-type="table-fn"}   6.1 (4.9)[\*](#t3n1){ref-type="table-fn"}[‡](#t3n2){ref-type="table-fn"}   0.063
  Increase exercise levels         1.9 (3.3)   2.8 (3.7)   0.882      8.7 (4.0)[\*](#t3n1){ref-type="table-fn"}    5.5 (4.9)[\*](#t3n1){ref-type="table-fn"}   \<0.001   4.6 (5.1)[\*](#t3n1){ref-type="table-fn"}[‡](#t3n2){ref-type="table-fn"}   3.2 (4.6)[‡](#t3n2){ref-type="table-fn"}                                   0.096

Data represent mean (SD) number of weeks in the past 3 months that the behavior was endorsed.

\*Value is significantly different from baseline value (*P* \< 0.05).

‡Value is significantly different from 3-month value (*P* \< 0.05).

Conclusions {#s16}
===========

The Rx Weight Loss Trial found that overweight and obese patients referred by their physician to an Internet behavioral weight-loss program lost on average 5.5 kg at the end of the 3-month program and maintained this weight loss in full at 6 months. In addition, 53% achieved a clinically significant weight loss of at least 5% of initial body weight at 3 months and 48% at 6 months. These results far exceeded the weight losses achieved by the patients who were randomly assigned to an Internet newsletter control condition and provide an effective, potentially low-cost option that physicians could use with their overweight and obese patients to reduce the risk of type 2 diabetes and other weight-related diseases.

Engagement with the IBI website was quite high during treatment and correlated with weight-loss outcomes. Prior work suggests that feedback messages, perhaps to an even greater degree than online lessons, contributed to improved weight-loss outcomes in similar programs ([@B26]). IBI participants also reported more frequent use of key behaviors, such as reducing calorie and fat intake, than was seen in IDEA. This suggests that successful skills acquisition and implementation is at least partially responsible for the superior weight losses in IBI. The use of key strategies was greatest during the 3-month treatment and then appeared to decrease; this finding emphasizes the need to develop approaches to maintaining adherence to these behaviors longer term. Likewise, additional research could be helpful in determining the relative importance of IBI components (e.g., goal-setting, lessons, self-monitoring, feedback, and reports to referring physicians).

Weight losses in the IBI condition appear to exceed those we achieved using a similar 3-month intervention in a community setting (3.5 kg weight loss at 3 months) ([@B26]). This difference in outcome may reflect differences in the two study groups. For example, participants referred by physicians may have more health concerns and therefore greater motivation to lose weight compared with individuals participating in a community wellness campaign. The difference may also suggest that there are added beneficial effects from physicians' referrals and their involvement in the process. For example, the letters sent monthly to physicians (and copied to patients) reporting weight-loss progress may have increased the patients' sense of accountability for their weight-loss success. Further research is needed to determine whether involving the physician improves outcomes and how best to maximize this effect.

Previous studies of weight-loss interventions in primary care settings have primarily involved physician counseling, physician counseling combined with weight-loss medications, or delivery of the intervention by other office staff ([@B27]). In many cases, the interventions were not based on empirically tested behavioral weight-loss strategies, and the results of these studies have been variable ([@B27]). We are aware of few studies that used web-based approaches in primary care, and as noted above, many of these have involved substantial face-to-face ([@B27],[@B28]) or remote counseling ([@B16]--[@B19]). Our results suggest that comparable weight losses, at least initially, can be achieved with a nearly (i.e., with the exception of the randomization/program kickoff visit) fully automated Internet program. Likewise, our findings appear consistent with efforts to translate behavioral weight-loss interventions, such as the DPP, for delivery by medical and allied health professionals and in community settings that have achieved mean weight loss of 3.2--4.3% of initial body weight after 12 months ([@B11]). Compared with these other efforts, the Rx Weight Loss approach may incur fewer problems with cost, reach, accessibility, and long-term sustainability that have been a cause for concern with programs delivered in-person ([@B11]).

There are several limitations to this study. First, the study lasted only 6 months, and thus, it is not clear if these weight losses will be maintained long term. Since participants in behavioral weight-loss programs typically lose weight for the first 3--6 months of treatment ([@B8]) and then gradually regain weight, our study did not follow participants through the period during which they are at greatest risk of regain. Previous studies have consistently shown that continued contact is important for maintaining weight losses ([@B8]); providing further ongoing intervention and tailoring of the program to specific needs of the participant may promote long-term efficacy ([@B29],[@B30]). Second, the study required several visits to an academic medical center that may have influenced outcomes. At the randomization/program kickoff visit, both groups were seen face-to-face and introduced to the website and the key elements of the weight-loss intervention (self-monitoring and goal-setting) were reviewed with participants in IBI. In the future, this information could be presented to participants via Internet-streamed video. Third, although some physicians referred many more patients than others (data not shown), we do not know the factors that influenced this. Nor do we know why some patients who agreed to a referral decided not to enroll. An exploration of factors affecting willingness of both physicians and patients to participate in such a program could be important if the program were to be made widely available. Fourth, while weight loss has been reliably shown to improve cardiovascular disease risk factors such as glucose control ([@B31]), we did not measure changes in these physiological indicators. Lastly, the sample had low racial and ethnic minority representation and was generally well educated; the generalizability of the results to other populations, including older adults and those with disabilities should be tested.

Strengths of the study include the system of referrals from physicians, which required very little time on their part, and the fact that the approach we used is nearly fully automated and can thus be scaled for use with large numbers of patients at minimal additional cost. Moreover, we compared the IBI program to a control group that received weekly printable lessons via the Internet, thus controlling for engagement with the website and ongoing attention to weight control. The clinically significant weight loss in IBI but not the control group suggests that physician advice to lose weight combined with common diet and exercise information is insufficient and that behavioral strategies and feedback are also required to produce meaningful weight loss.

In conclusion, physician referral to a behavioral Internet intervention, which includes weekly behavioral lessons and weekly automated feedback to patients on their self-monitoring records, with periodic written feedback to the physician, can be an effective approach for weight loss in overweight and obese individuals. Given that ∼80% of U.S. adults use the Internet ([@B32],[@B33]), this approach may provide a cost-effective alternative or complement to the face-to-face counseling models of obesity treatment, including that which is currently reimbursable by the Centers for Medicare & Medicaid Services ([@B34]), and could be paired with other Internet-based resources for diabetes management and risk reduction ([@B35]). Additional translational research is needed to determine whether this intervention can be fully implemented within current health care settings and reimbursement models while preserving the positive weight-loss outcomes.
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